Lymphangiogenesis and hemangiogenesis: Potential targets for therapy

This review updates historical background from century‐old observations on embryonic lymphatic system development through current understanding of the molecular basis of lymphvasculogenesis/lymphangiogenesis (“molecular lymphology”), highlighting similarities and differences with analogous blood vasculature processes. Topics covered include molecular mechanisms in lymphatic development, structural adaptations of the lymphatic vasculature to particulate and cellular transport and trafficking, lymphogenous route of clinical cancer spread, preservation of delineated lymphatic pathways during cancer operations, and anti‐lymphangiogenesis in cancer therapy. J. Surg. Oncol. 2011;103:489–500. © 2011 Wiley‐Liss, Inc.

[1]  S. Nathanson,et al.  The Role of Lymph Node Metastasis in the Systemic Dissemination of Breast Cancer , 2010, Indian journal of surgical oncology.

[2]  R. Ferrell,et al.  GJC2 missense mutations cause human lymphedema. , 2010, American journal of human genetics.

[3]  G. Oliver,et al.  Endothelial cell plasticity: how to become and remain a lymphatic endothelial cell , 2010, Development.

[4]  S. Nathanson,et al.  Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma , 1994, Annals of Surgical Oncology.

[5]  S. Mansour,et al.  Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia , 2010, Human Genetics.

[6]  J. Sleeman,et al.  Tumor metastasis and the lymphatic vasculature , 2009, International journal of cancer.

[7]  G. Christofori,et al.  Myeloid Cells Contribute to Tumor Lymphangiogenesis , 2009, PloS one.

[8]  J. Sleeman,et al.  Delphinidin inhibits a broad spectrum of receptor tyrosine kinases of the ErbB and VEGFR family. , 2009, Molecular nutrition & food research.

[9]  D. Sheppard,et al.  Integrin-α9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis , 2009, Developmental cell.

[10]  M. Rothley,et al.  Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor‐induced lymphangiogenesis in vivo , 2009, International journal of cancer.

[11]  Junhao Hu,et al.  FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1 , 2009, The Journal of cell biology.

[12]  J. Sleeman,et al.  Suppression of the kinase activity of receptor tyrosine kinases by anthocyanin-rich mixtures extracted from bilberries and grapes. , 2009, Journal of agricultural and food chemistry.

[13]  J. Sleeman,et al.  Tumor lymphatics. , 2009, Seminars in cancer biology.

[14]  R. Hennekam,et al.  Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans , 2009, Nature Genetics.

[15]  S. Ferrero,et al.  Lymphedema Microsurgical Preventive Healing Approach: A New Technique for Primary Prevention of Arm Lymphedema After Mastectomy , 2009, Annals of Surgical Oncology.

[16]  I. Fidler,et al.  Targeting the tumor microenvironment (Stroma) for treatment of metastasis , 2008 .

[17]  F. Orsenigo,et al.  Sox18 induces development of the lymphatic vasculature in mice , 2008, Nature.

[18]  M. Wong,et al.  Hematopoietic Stem Cells Contribute to Lymphatic Endothelium , 2008, PloS one.

[19]  M. Shibata,et al.  Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model , 2008, Cancer Gene Therapy.

[20]  G. Yancopoulos,et al.  Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. , 2008, Developmental biology.

[21]  A. Ruddell,et al.  p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis , 2008, Oncogene.

[22]  P. Carmeliet,et al.  Modeling lymphangiogenesis in a three-dimensional culture system , 2008, Nature Methods.

[23]  J. Luk,et al.  Serum Vascular Endothelial Growth Factor C Correlates With Lymph Node Metastases and High-Risk Tumor Profiles in Papillary Thyroid Carcinoma , 2008, Annals of surgery.

[24]  K. Alitalo,et al.  Molecular biology and pathology of lymphangiogenesis. , 2008, Annual review of pathology.

[25]  F. Orsenigo,et al.  Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees , 2008, Cell and Tissue Research.

[26]  I. Ellis,et al.  Improved Methods of Detection of Lymphovascular Invasion Demonstrate That It is the Predominant Method of Vascular Invasion in Breast Cancer and has Important Clinical Consequences , 2007, The American journal of surgical pathology.

[27]  K. Miyazono,et al.  Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. , 2007, Cancer research.

[28]  M. Tsai,et al.  Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. , 2007, Genes & development.

[29]  Elisabetta Dejana,et al.  Functionally specialized junctions between endothelial cells of lymphatic vessels , 2007, The Journal of experimental medicine.

[30]  R. Erickson,et al.  Chy‐3 mice are Vegfc haploinsufficient and exhibit defective dermal superficial to deep lymphatic transition and dermal lymphatic hypoplasia , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[31]  W. Svensson,et al.  Human lymphatic pumping measured in healthy and lymphoedematous arms by lymphatic congestion lymphoscintigraphy , 2007, The Journal of physiology.

[32]  C. Nos,et al.  Blue Dye Injection in the Arm in Order to Conserve the Lymphatic Drainage of the Arm in Breast Cancer Patients Requiring an Axillary Dissection , 2007, Annals of Surgical Oncology.

[33]  V. Klimberg,et al.  Axillary Reverse Mapping (ARM): A New Concept to Identify and Enhance Lymphatic Preservation , 2007, Annals of Surgical Oncology.

[34]  D. Dumont,et al.  Lymphangiogenesis following obstruction of large postnodal lymphatics in sheep. , 2007, Microvascular research.

[35]  M. Deng,et al.  Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer. , 2007, World journal of gastroenterology.

[36]  A. Ruddell,et al.  Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. , 2007, The American journal of pathology.

[37]  K. Alitalo,et al.  VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. , 2007, Blood.

[38]  G. Azzali.  Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate. , 2007, The American journal of pathology.

[39]  P. Sismondi,et al.  Axillary Reverse Mapping in Breast Cancer: Can we Spare what we Find? , 2007, Annals of Surgical Oncology.

[40]  G. Vlastos,et al.  Lymphedema following axillary lymph node dissection for breast cancer. , 2006, Surgical oncology.

[41]  E. van Marck,et al.  Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer , 2006, British Journal of Cancer.

[42]  Dai Fukumura,et al.  Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. , 2006, Cancer research.

[43]  J. Gershenwald,et al.  Structure function relationships in the lymphatic system and implications for cancer biology , 2006, Cancer and Metastasis Reviews.

[44]  Ruijin Huang,et al.  Dual origin of avian lymphatics. , 2006, Developmental biology.

[45]  D. Kerjaschki,et al.  Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants , 2006, Nature Medicine.

[46]  H. Spring,et al.  Chemokines direct endothelial progenitors into tumor neovessels. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Sleeman,et al.  Hyperforin acts as an angiogenesis inhibitor. , 2005, Planta medica.

[48]  Yihai Cao,et al.  Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Ohkuma,et al.  Nature's historic gap: the 20th century of lymphology. , 2005, Lymphology.

[50]  S. Hirakawa,et al.  Hepatocyte growth factor promotes lymphatic vessel formation and function , 2005, The EMBO journal.

[51]  Kris Vleminckx,et al.  A genetic Xenopus laevis tadpole model to study lymphangiogenesis , 2005, Nature Medicine.

[52]  P. Brown.  Lymphatic system: Unlocking the drains , 2005, Nature.

[53]  K. Alitalo,et al.  Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. , 2005, Blood.

[54]  K. Alitalo,et al.  Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. , 2005, Blood.

[55]  Satoshi Hirakawa,et al.  VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis , 2005, The Journal of experimental medicine.

[56]  G. A. Wilkinson,et al.  PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. , 2005, Genes & development.

[57]  J. Sleeman,et al.  Aristoforin, a Novel Stable Derivative of Hyperforin, Is a Potent Anticancer Agent , 2005, Chembiochem : a European journal of chemical biology.

[58]  J. Sleeman,et al.  MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo , 2004, International journal of cancer.

[59]  Toshio Ohhashi,et al.  PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. , 2004, Cancer cell.

[60]  K. Alitalo,et al.  Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis , 2004, Nature Medicine.

[61]  Rakesh K. Jain,et al.  Pathology: Cancer cells compress intratumour vessels , 2004, Nature.

[62]  J. Partanen,et al.  Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins , 2004, Nature Immunology.

[63]  S. Nathanson,et al.  Insights into the mechanisms of lymph node metastasis , 2003, Cancer.

[64]  K. Devriendt,et al.  Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. , 2003, American journal of human genetics.

[65]  Marlys H Witte,et al.  FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. , 2003, Human molecular genetics.

[66]  J. Sleeman,et al.  Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. , 2003, Cancer research.

[67]  P. Campochiaro,et al.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. , 2002, Developmental cell.

[68]  K. Alitalo,et al.  Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Jeffrey E Gershenwald,et al.  Targeting Lymphatic Metastasis , 2002, Science.

[70]  M. Detmar,et al.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype , 2002, The EMBO journal.

[71]  C. Borner,et al.  Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis , 2002, Oncogene.

[72]  J. Sleeman,et al.  Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. , 2001, European journal of biochemistry.

[73]  M. Witte,et al.  Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology , 2001, Microscopy research and technique.

[74]  R. Kauppinen,et al.  A model for gene therapy of human hereditary lymphedema , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[75]  T. Veikkola,et al.  Signalling via vascular endothelial growth factor receptor‐3 is sufficient for lymphangiogenesis in transgenic mice , 2001, The EMBO journal.

[76]  Steven A. Stacker,et al.  VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.

[77]  M. W. Glynn,et al.  Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. , 2000, American journal of human genetics.

[78]  Robert E. Ferrell,et al.  Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema , 2000, Nature Genetics.

[79]  G. Oliver,et al.  Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.

[80]  M. Ross,et al.  Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  M. Witte,et al.  On tumor (and other) lymphangiogenesis. , 1997, Lymphology.

[82]  K. Alitalo,et al.  VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. , 1997, Developmental biology.

[83]  R. Jain,et al.  Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.

[84]  M. Witte,et al.  Lymphangiogenesis: mechanisms, significance and clinical implications. , 1997, EXS.

[85]  K. Alitalo,et al.  A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. , 1996, The EMBO journal.

[86]  R. Foster.  General anatomy of the lymphatic system. , 1996, Surgical oncology clinics of North America.

[87]  M. Ross,et al.  The Orderly Progression of Melanoma Nodal Metastases , 1994, Annals of surgery.

[88]  S. Hellman,et al.  Karnofsky Memorial Lecture. Natural history of small breast cancers. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  F. Hetzel,et al.  Relationship of spontaneous regional lymph node metastases to dose of local irradiation of primary B16 melanomas. , 1989, Cancer research.

[90]  L. Liotta,et al.  Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.

[91]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[92]  R. M. H. Mcminn,et al.  Evolution and Comparative Morphology of the Lymphatic System , 1970 .

[93]  B. Fisher,et al.  The interrelationship of hematogenous and lymphatic tumor cell dissemination. , 1966, Surgery, gynecology & obstetrics.

[94]  E. R. Clark,et al.  Observations on the new growth of lymphatic vessels as seen in transparent chambers introduced into the rabbit's ear , 1932 .

[95]  O. F. Kampmeier.  Further observations on the numerical variability, position, function, and fate of the valves in the human thoracic duct , 1928 .

[96]  Otto F. Kampmeier,et al.  The development of the thoracic duct in the pig : a dissertation presented to the Faculty of Princeton University in Candidacy for the degree of Doctor of Philosophy , 1912 .

[97]  Charles F. McClure,et al.  A few remarks relative to Mr. Kampmeier's paper on ‘the value of the injection method in the study of lymphrtic development’ , 1912 .

[98]  O. F. Kampmeier,et al.  The value of the injection method in the study of lymphatic development , 1912 .

[99]  F. Sabin.  A critical study of the evidence presented in several recent articles on the development of the lymphatic system , 1911 .

[100]  E. R. Clark.  Observations on living growing lymphatics in the tail of the frog larva , 1909 .

[101]  F. Sabin.  The Lymphatic System in Human Embryos, with a Consideration of the Morphology of the System As a Whole , 1909 .

[102]  W. Halsted.  I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. , 1907, Annals of surgery.

[103]  F. Sabin.  On the development of the superficial lymphatics in the skin of the pig , 1904 .

[104]  F. Sabin.  On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig , 1902 .